Heron Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Heron Therapeutics's performance 

Heron Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Heron Therapeutics's performance  Earnings estimates and surprises for Heron Therapeutics (HRTX) are an important tool used to evaluate Analyst Target Prices Earnings Per Share ttm , -2.50. Explore commentary on Heron Therapeutics Inc. and hear what the experts at TheStreet are Pacira price target raised to $63 from $60 at H.C. Wainwright. 4 Mar 2020 The 1-year high price for the company's stock is recorded $28.65 on 03/05/19, with the The Analysts eye on Heron Therapeutics, Inc. (HRTX). Future Growth. How is Heron Therapeutics forecast to perform in the next 1 to 3 years based on estimates from 9 analysts? Analysis Checks 5/ 

After Cantor Fitzgerald and Stifel Nicolaus gave Heron Therapeutics (NASDAQ: HRTX) a Buy rating last month, the company received another Buy, this time from Cowen & Co. Analyst Boris Peaker maintained a Buy rating on Heron Therapeutics today and set a price target of $40.00. The company’s shares closed last Monday at $21.66.

See Heron Therapeutics price target based on 7 analysts offering 12 month price targets for Heron Therapeutics in the last 3 months. The average price target is $35.57 with a high forecast of $44.00 and a low forecast of $28.00. The average price target represents a … Heron Therapeutics, Inc. Common Stock (HRTX) Stock Quotes ... Heron Therapeutics, Inc. Common Stock (HRTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. HRTX Heron Therapeutics Inc. — Stock Price ... - StockTwits Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures.

14 Apr 2019 Conversely, if the same company with a $60 share price has a good quarter and analysts increase its price target from $70 to $80, more investors 

Oct 31, 2017 · Heron Therapeutics (NASDAQ:HRTX) initiated with Outperform rating and $27 (76% upside) price target by Oppenheimer. Voyager Therapeutics (NASDAQ:VYGR) initiated with Outperform rating and $31 (37% Do Analysts Recommend You Should Buy Heron Therapeutics ... On Monday, shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) marked $20.93 per share versus a previous $21.45 closing price. With having a -2.42% loss, an insight into the fundamental values of Heron Therapeutics, Inc., investors would also find a great ally in the technical patterns of the stock movements showed in stock charts. Heron Therapeutics Inc : HRTX Stock Price Quote at Ally Invest Analyst Actions: Needham & Co Cuts Heron Therapeutics Price Target to $48 From $50, Maintains Buy Rating 11:13AM ET 2/20/2020 MT Newswires. Heron Therapeutics' (HRTX) average rating among analysts is a buy, with an average price target of $47. Heron Therapeutics Analysts | Markets Insider

HRTX | Heron Therapeutics Inc. SEC Filings | MarketWatch

Aug 07, 2019 · Today we look at Heron Therapeutics Northland Securities assigned a new Buy rating and $55 price target on Heron Monday as well. The stock seems to … Heron Therapeutics (HRTX) Stock Advancing on Positive ... Jun 30, 2015 · Shares of Heron Therapeutics - Get Report are rising, up 4.77% to $30.87 after JMP Securities increased its price target to $33 from $25 while … Pharma stock to watch: Heron Therapeutics Inc (NASDAQ: HRTX) Apr 06, 2018 · Heron Therapeutics (NASDAQ: HRTX) stock price target raised by Needham & Company LLC to $42.00 in a research report published on March 20th. The brokerage currently has a … News Releases | Heron Therapeutics

Heron Therapeutics, Inc. is a biotechnology company, which engages in the development of pharmaceutical products for patients suffering from cancer. Its products portfolio include SUSTOL, Cinvanti, HTX-011, and HTX-034. The company was founded in February 1983 and is headquartered in Redwood City, CA.

Find the latest Heron Therapeutics, Inc. (HRTX) stock quote, history, news and other vital information to help you with your stock trading and investing. HRTX | Heron Therapeutics Inc. Analyst Estimates & Rating ... Heron Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. HRTX updated stock price target summary. HRTX Stock Quote - Heron Therapeutics, Inc. Common Stock ... Stock quote for Heron Therapeutics, Inc. Common Stock Common Stock (HRTX) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.

Heron Therapeutics, Inc. Common Stock (HRTX) Real-Time ... HRTX Real Time Stock Quote - Get Heron Therapeutics, Inc. Common Stock (HRTX) last sale data in real-time at NASDAQ.com. Our Businesses. "Last Sale" is the price at which a stock last traded during regular market hours. This will now be your default target page; unless you change your configuration again, or you delete your cookies. Heron Therapeutics Price Target | HRTX In depth view into Heron Therapeutics Price Target including historical data from 1987, charts, stats and industry comps. HRTX | Heron Therapeutics Inc. SEC Filings | MarketWatch